Liposomal cytarabine (DepoCyte®) for the treatment of neoplastic meningitis

Clinical and Translational Oncology

Volumn 7, Issue 6, 2005, Pages 232-238

  Domínguez, Antonio Rueda ^a   Hidalgo, David Olmos ^a   Garrido, Ruth Viciana ^a   Sánchez, Esperanza Torres ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

Liposomal cytarabine; Neoplastic meningitis; Treatment

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CYTARABINE; LIPOSOME;

CLINICAL TRIAL; HUMAN; INTRASPINAL DRUG ADMINISTRATION; MENINGIOMA; MENINGITIS; METASTASIS; REVIEW;

ANTIMETABOLITES, ANTINEOPLASTIC; CLINICAL TRIALS; CYTARABINE; HUMANS; INJECTIONS, SPINAL; LIPOSOMES; MENINGEAL NEOPLASMS; MENINGITIS;

EID: 32944480768     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/BF02710168     Document Type: Review

References (21)

1. Herman TS, Hammond N, Jones S.E., et al Involvement of the central nervous system by non-Hodgkin's lymphoma: the Southwest Oncology Group experience. Cancer. 1979; 43: 390-7.
2. Bleyer WA. Leptomeningeal cancer in leukaemia and solid tumors. Curr Probl Cancer. 1988; 12: 184-238.
3. Wasserstrom WR, Glass JP, Posner J.B., et al Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer. 1982; 49: 759-72.
4. Boogerd W, Hart AAM, Van der Sande JJ, et al. Meningeal carcinomatosis in breast cancer. Cancer. 1991; 67: 1685-95.
5. Chamberlain MC, Kormanik PA Non-AIDS-related lymphomatous meningitis: combined modality therapy. Neurology. 1997; 49: 1728-31.
6. Chamberlain MC, Dirr L. Involved field radiotherapy and intra-ommaya methotrexate/ara-C in patients with AIDS-related lymphomatous meningitis. J Clin Oncol. 1993; 11: 1979-84.
7. Giannone L, Greco FA, Hainsworth J.D., et al Combination intaventricular chemotherapy for meningeal neoplasia. J Clin Oncol. 1986; 4: 68-73.
8. Grossman SA, Finkelstein MD, Ruckdeschek J.C., et al Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. J Clin Oncol. 1993; 11: 561-9.
9. Hitchins RN, Bell DR, Woods R.L., et al A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol. 1987; 5: 1655-62.
10. Graham FL, Whitmore GF The effect of 1-beta-D-arabi-nofuranosylcytosine on growth, viability, and DNA syn-tesis of mouse L-cells. Cancer Res. 1970; 30: 2627-35.
11. Zimm S, Collins JM, Miser J, et al Cytosine arabinoside cerebrospinalfluid kinetics. Clin Pharmacol Ther. 1984; 35: 826-30.
12. Kohn FR, Malkmus SA, Brownson E.A., et al Fate of the predominant phospholipid component of DepoFoam drug delivery matrix after intrathecal administration of sustained-release encapsulated cytarabine in rats. Drugs Delivery. 1998; 5: 143-51.
13. Chamberlain MC, Kormanik P, Howell S.B., Kim S. Pharmacokinetics of intralumbar DTC-101 for the treatment of leptomeningeal metastases. Arch Neurol. 1995; 52: 912-7
14. Frei E, Bickers JN, Hewlett J.S., et al Dose schedule and antitumor studies of arabinosyl cytosine (NSSC 63878). Cancer Res. 1969; 29: 1325-32.
15. Kim S, Chatelut E, Kim J.C., et al Extended CSF citarabi-ne exposure following intrathecal administration of DTC 101. J Clin Oncol. 1993; 11: 2186-93.
16. Chamberlain MC, Khatibi S, Kim J.C., Howell SB, Chatelut E, Kim S. Treatment of leptomenigeal metastasis with intraventicular administration of depot cytarabine (DTC 101). Arch Neurol. 1993; 50: 261-4.
17. Glantz MJ, Lafollete S, Jaeckle K.A., et al Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphoma-tous meningitis. J Clin Oncol. 1999; 17: 3110-6.
18. Glantz MJ, Jaeckle KA, Chamberlain M.C., et al A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res. 1999; 5: 3394-402.
19. Jaeckle KA, Phuphanich S, Bent M.J., et al Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine. Br J Cancer. 2001; 84: 157-63.
20. Jaeckle KA, Batchelor T, O'Day SJ, et al An open label trial of sustsined-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis. J Neurooncol. 2002; 57: 231-9.
21. Haioun C, Besson C, Lepage E., et al Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated an receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Ann Oncol. 2000; 11: 685-90.